1
|
Jiménez C, Bordagaray MJ, Villarroel JL, Flores T, Benadof D, Fernández A, Valenzuela F. Biomarkers in Oral Fluids as Diagnostic Tool for Psoriasis. Life (Basel) 2022; 12:life12040501. [PMID: 35454992 PMCID: PMC9027180 DOI: 10.3390/life12040501] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2022] [Revised: 03/11/2022] [Accepted: 03/27/2022] [Indexed: 12/13/2022] Open
Abstract
Psoriasis is a prevalent worldwide chronic immuno-inflammatory skin disease with various variants and atypical cases. The use of biomarkers for the diagnosis of psoriasis can favor timely treatment and thus improve the quality of life of those affected. In general, the search for biomarkers in oral fluids is recommended as it is a non-invasive and fast technique. This narrative review aimed to identify biomarkers in gingival crevicular fluid (GCF) and saliva to diagnose psoriasis. To achieve this goal, we selected the available literature using the following MESH terms: “psoriasis”, “saliva” and “gingival crevicular fluid”. The studies analyzed for this review cover original research articles available in English. We found three full articles available for psoriasis biomarkers in GCF and ten articles available for psoriasis biomarkers in saliva. Studies showed that in the saliva of healthy individuals and those with psoriasis, there were differences in the levels of inflammatory cytokines, immunoglobulin A, and antioxidant biomarkers. In GCF, individuals with psoriasis showed higher levels of S100A8, IL-18 and sE-selectin in comparison to healthy individuals, independent of periodontal status. Despite these findings, more studies are required to determine an adequate panel of biomarkers to use in saliva or GCF for psoriasis.
Collapse
Affiliation(s)
- Constanza Jiménez
- Faculty of Dentistry, Universidad Andres Bello, Santiago 8370133, Chile; (C.J.); (D.B.)
| | - María José Bordagaray
- Department of Conservative Dentistry, Faculty of Dentistry, Universidad de Chile, Santiago 8380544, Chile;
| | - José Luis Villarroel
- Department of Dermatology, Faculty of Medicine, Universidad de Chile, Santiago 8380453, Chile;
| | - Tania Flores
- Research Centre in Dental Science (CICO), Faculty of Dentistry, Universidad de La Frontera, Temuco 4780000, Chile;
| | - Dafna Benadof
- Faculty of Dentistry, Universidad Andres Bello, Santiago 8370133, Chile; (C.J.); (D.B.)
| | - Alejandra Fernández
- Faculty of Dentistry, Universidad Andres Bello, Santiago 8370133, Chile; (C.J.); (D.B.)
- Correspondence: (A.F.); (F.V.); Tel.: +56-2-2661-5834 (A.F.); +56-2-2978-8173 (F.V.)
| | - Fernando Valenzuela
- Department of Dermatology, Faculty of Medicine, Universidad de Chile, Santiago 8380453, Chile;
- Correspondence: (A.F.); (F.V.); Tel.: +56-2-2661-5834 (A.F.); +56-2-2978-8173 (F.V.)
| |
Collapse
|
2
|
Kumar V. Going, Toll-like receptors in skin inflammation and inflammatory diseases. EXCLI JOURNAL 2021; 20:52-79. [PMID: 33510592 PMCID: PMC7838829 DOI: 10.17179/excli2020-3114] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/01/2020] [Accepted: 01/04/2021] [Indexed: 02/06/2023]
Abstract
The Indian Ayurvedic physicians knew the concept of inflammation dating back to 1500 BC. The continuous progress in the immunology of inflammation has explained its undiscovered mechanisms. For example, the discovery of Toll-like receptor 4 (TLR4) in humans (1997) has revolutionized the field of infection biology and innate immunity. The laboratory mice have shown twelve TLRs and express TLR10 (CD290) as a disrupted pseudogene, and humans have ten functional TLRs. Now, it is well established that TLRs play a significant role in different infectious and inflammatory diseases. Skin inflammation and other associated inflammatory diseases, including atopic dermatitis (AD), acne vulgaris, and psoriasis, along with many skin cancers are major health problems all over the world. The continuous development in the immunopathogenesis of inflammatory skin diseases has opened the window of opportunity for TLRs in studying their role. Hence, the manuscript explores the role of different TLRs in the pathogenesis of skin inflammation and associated inflammatory diseases. The article starts with the concept of inflammation, its origin, and the impact of TLRs discovery on infection and inflammation biology. The subsequent section describes the burden of skin-associated inflammatory diseases worldwide and the effect of the geographical habitat of people affecting it. The third section explains skin as an immune organ and explains the expression of different TLRs on different skin cells, including keratinocytes, Langerhans cells (LCs), skin fibroblasts, and melanocytes. The fourth section describes the impact of TLRs on these cells in different skin-inflammatory conditions, including acne vulgaris, AD, psoriasis, and skin cancers. The article also discusses the use of different TLR-based therapeutic approaches as specific to these inflammatory skin diseases.
Collapse
Affiliation(s)
- Vijay Kumar
- Children Health Clinical Unit, Faculty of Medicine and Biomedical Sciences, Mater Research, University of Queensland, ST Lucia, Brisbane, Queensland 4078, Australia
- School of Biomedical Sciences, Faculty of Medicine, University of Queensland, ST Lucia, Brisbane, Queensland 4078, Australia
| |
Collapse
|
3
|
Youssef R, Abdel-Halim MRE, Kamel M, Khorshid M, Fahim A. Effect of polymorphisms in IL-12B p40, IL-17A and IL-23 A/G genes on the response of psoriatic patients to narrowband UVB. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE 2018; 34:347-349. [PMID: 29763989 DOI: 10.1111/phpp.12395] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 05/04/2018] [Indexed: 11/27/2022]
Affiliation(s)
- Randa Youssef
- Dermatology Department, Cairo University, Cairo, Egypt
| | | | - Marwa Kamel
- Dermatology Department, Cairo University, Cairo, Egypt
| | - Mervat Khorshid
- Clinical Pathology Department, Cairo University, Cairo, Egypt
| | - Aya Fahim
- Dermatology Department, Cairo University, Cairo, Egypt
| |
Collapse
|
4
|
Rui W, Xiangyu D, Fang X, Long G, Yi Y, Wenjuan W, Tian H, Xiaoning Z, Yong Z, Jianfeng F, Hengjin L, Chengxin L. Metabolic syndrome affects narrow-band UVB phototherapy response in patients with psoriasis. Medicine (Baltimore) 2017; 96:e8677. [PMID: 29390261 PMCID: PMC5815673 DOI: 10.1097/md.0000000000008677] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Psoriasis is a chronic inflammatory skin disease. Metabolic syndrome (MS) is a combination of central obesity, dyslipidemia, glucose intolerance, and elevated blood pressure. Many epidemiological surveys have revealed the association of psoriasis with MS. Narrowband ultraviolet radiation b (NB-UVB) is an effective and widely used treatment for psoriasis. The purpose of this study was to investigate whether the presence of MS in patient with psoriasis affects NB-UVB treatment and whether this syndrome correlates with systemic inflammation.From June 2016 to December 2016, 243 adults with a diagnosis of psoriasis vulgaris eligible to treatment with NB-UVB were admitted to the phototherapy unit of Dermatology department, Chinese PLA General Hospital. Fifty-five included patients were grouped based on the presence of MS. They accepted the treatment of NB-UVB and the following data were collected: serum levels of IL-17 (interleukin), TNF-α (tumor necrosis factor) and IL-6, Psoriasis Area and Severity Index (PASI) scores before and after 10 sections of NB-UVB treatment.Significant PASI improvement was observed in psoriatic patients without MS after 10 sections of phototherapy, while patients with MS showed a less improvement (P < .001). There was statistically significant difference in percentage of patients achieving 50% reduction in PASI scores between the 2 groups (P < .05). Multivariate logistic regression analysis showed MS was an independent factor that affecting the treatment of NB-UVB (P < .05). Psoriatic patients with MS showed a much less reduction of IL-17 and IL-6 before and after 10 sections of NB-UVB treatment respectively than patients without MS (P < .05).Psoriatic patients with MS have poorer improvement in comparison those without MS using NB-UVB treatment. MS was an independent factor that affecting the treatment of NB-UVB. In addition, psoriatic patients with MS showed a much less reduction of systemic biomarkers (interleukin-IL-17, TNF-α, IL-6) than patients without MS. Namely, they may need a longer course of treatment to achieve improved skin lesions.
Collapse
|
5
|
The significance of Toll-like receptor (TLR) 2 and 9 gene polymorphisms in psoriasis. Postepy Dermatol Alergol 2017; 34:85-86. [PMID: 28261037 PMCID: PMC5329111 DOI: 10.5114/ada.2017.65628] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2016] [Accepted: 04/20/2016] [Indexed: 01/12/2023] Open
|
6
|
Nishikawa R, Nagai H, Bito T, Ikeda T, Horikawa T, Adachi A, Matsubara T, Nishigori C. Genetic prediction of the effectiveness of biologics for psoriasis treatment. J Dermatol 2016; 43:1273-1277. [DOI: 10.1111/1346-8138.13412] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2016] [Accepted: 03/08/2016] [Indexed: 12/31/2022]
Affiliation(s)
- Rika Nishikawa
- Division of Dermatology; Department of Internal Related; Faculty of Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| | - Hiroshi Nagai
- Division of Dermatology; Department of Internal Related; Faculty of Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| | - Toshinori Bito
- Division of Dermatology; Department of Internal Related; Faculty of Medicine; Kobe University Graduate School of Medicine; Kobe Japan
- Bito Dermatology Clinic; Kobe Japan
| | - Tetsuya Ikeda
- Department of Dermatology; Kobe City Hospital Organization Kobe Medical Center West Hospital; Kobe Japan
| | | | - Atsuko Adachi
- Department of Dermatology; Hyogo Prefectural Kakogawa Medical Center; Kakogawa Japan
| | | | - Chikako Nishigori
- Division of Dermatology; Department of Internal Related; Faculty of Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| |
Collapse
|
7
|
Traks T, Keermann M, Karelson M, Rätsep R, Reimann E, Silm H, Vasar E, Kõks S, Kingo K. Polymorphisms in Toll-like receptor genes are associated with vitiligo. Front Genet 2015; 6:278. [PMID: 26442097 PMCID: PMC4563240 DOI: 10.3389/fgene.2015.00278] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2015] [Accepted: 08/19/2015] [Indexed: 12/15/2022] Open
Abstract
Background: The members of Toll-like receptor (TLR) family are responsible for recognizing various molecular patterns associated with pathogens. Their expression is not confined to immune cells and have been detected in skin cells such as keratinocytes and melanocytes. As part of a generated response to pathogens, TLRs are involved in inducing inflammatory mediators to combat these threats. It is therefore not surprising that TLRs have been implicated in inflammatory skin diseases, including atopic dermatitis and psoriasis. Likewise, as key players in autoimmunity, they have been associated with a number of autoimmune diseases. Based on this, the role of TLRs in vitiligo could be suspected, but is yet to be clearly established. Methods: In order to conduct a genetic association analysis, 30 SNPs were selected from TLR1-TLR8 and TLR10 regions to be genotyped in Estonian case-control cohort consisting of 139 vitiligo patients and 307 healthy control individuals. The patients were further analyzed in subgroups based on sex, age of onset, occurrence of vitiligo among relatives, extent of depigmented areas, vitiligo progression activity, appearance of Köbner's phenomenon, existence of halo naevi, and incidence of spontaneous repigmentation. Results: The most notable finding came with SNP rs179020 situated in TLR7 gene, that was associated in entire vitiligo (Padj = 0.0065) and also several subgroup analyses. Other single marker and haplotype analyses pointed to TLR3, TLR4, and TLR10 genes. Conclusions: This study investigated the genetic regions of nine TLR genes in relation to vitiligo susceptibility. The main results were the associations of TLR7 SNPs with vitiligo, while several other associations were obtained from the remaining TLR gene regions. This suggests that in addition to other inflammatory skin diseases, TLRs affect the development of vitiligo, thus making them interesting targets for future research.
Collapse
Affiliation(s)
- Tanel Traks
- Department of Dermatology, University of Tartu Tartu, Estonia ; Centre of Excellence for Translational Medicine, University of Tartu Tartu, Estonia
| | - Maris Keermann
- Department of Dermatology, University of Tartu Tartu, Estonia ; Clinic of Dermatology, Tartu University Hospital Tartu, Estonia
| | - Maire Karelson
- Department of Dermatology, University of Tartu Tartu, Estonia ; Clinic of Dermatology, Tartu University Hospital Tartu, Estonia
| | - Ranno Rätsep
- Department of Physiology, University of Tartu Tartu, Estonia
| | - Ene Reimann
- Department of Pathophysiology, University of Tartu Tartu, Estonia ; Department of Reproductive Biology, Estonian University of Life Sciences Tartu, Estonia
| | - Helgi Silm
- Department of Dermatology, University of Tartu Tartu, Estonia ; Clinic of Dermatology, Tartu University Hospital Tartu, Estonia
| | - Eero Vasar
- Centre of Excellence for Translational Medicine, University of Tartu Tartu, Estonia ; Department of Physiology, University of Tartu Tartu, Estonia
| | - Sulev Kõks
- Centre of Excellence for Translational Medicine, University of Tartu Tartu, Estonia ; Department of Pathophysiology, University of Tartu Tartu, Estonia ; Department of Reproductive Biology, Estonian University of Life Sciences Tartu, Estonia
| | - Külli Kingo
- Department of Dermatology, University of Tartu Tartu, Estonia ; Clinic of Dermatology, Tartu University Hospital Tartu, Estonia
| |
Collapse
|